Cardiovascular risk factor in HIV Mexican population on antiretroviral therapy

Our aim was determine cardiovascular risk in HIV Mexican patients according to Framingham score after starting antiretroviral therapy. A retrospective study was conducted from March 1 to August 30 2012, at Hospital de Infectologia 'La Raza' National Medical Center in Mexico City. We enroll...

Full description

Saved in:
Bibliographic Details
Published in:Antiviral therapy 2013-01, Vol.18, p.A45-A46
Main Authors: Mata-Marin, J A, Santiago-Garcia, L I, Manjarrez-Tellez, B, Gaytan-Martinez, J E, Sandoval-Ramirez, J L
Format: Article
Language:English
Subjects:
Human immunodeficiency virus
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Our aim was determine cardiovascular risk in HIV Mexican patients according to Framingham score after starting antiretroviral therapy. A retrospective study was conducted from March 1 to August 30 2012, at Hospital de Infectologia 'La Raza' National Medical Center in Mexico City. We enrolled HIV naive infected patients and we followed-up until week 48. HIV treatment naive Mexican population had a mild increase of cardiovascular risk by Framingham score after 48 weeks of antiretroviral therapy. An increase of triglycerides, cholesterol and BMI were common in this population.
ISSN:1359-6535